Actomyosin-mediated cellular tension promotes Yap nuclear translocation and myocardial proliferation through α5 integrin signaling.
Xiaofei LiCallie McLainMichael Susithiran SamuelMichael F OlsonGlenn L RadicePublished in: Development (Cambridge, England) (2023)
The cardiomyocyte phenotypic switch from a proliferative to terminally differentiated state results in the loss of regenerative potential of the mammalian heart shortly after birth. Nonmuscle myosin IIB (NM IIB)-mediated actomyosin contractility regulates cardiomyocyte cytokinesis in the embryonic heart, and NM IIB levels decline after birth, suggesting a role for cellular tension in the regulation of cardiomyocyte cell cycle activity in the postnatal heart. To investigate the role of actomyosin contractility in cardiomyocyte cell cycle arrest, we conditionally activated ROCK2 kinase domain (ROCK2:ER) in the murine postnatal heart. Here, we show that α5/β1 integrin and fibronectin matrix increase in response to actomyosin-mediated tension. Moreover, activation of ROCK2:ER promotes nuclear translocation of Yap, a mechanosensitive transcriptional co-activator, and enhances cardiomyocyte proliferation. Finally, we show that reduction of myocardial α5 integrin rescues the myocardial proliferation phenotype in ROCK2:ER hearts. These data demonstrate that cardiomyocytes respond to increased intracellular tension by altering their intercellular contacts in favor of cell-matrix interactions, leading to Yap nuclear translocation, thus uncovering a function for nonmuscle myosin contractility in promoting cardiomyocyte proliferation in the postnatal heart.
Keyphrases
- cell cycle
- angiotensin ii
- heart failure
- signaling pathway
- high glucose
- atrial fibrillation
- preterm infants
- left ventricular
- cell cycle arrest
- stem cells
- cell proliferation
- estrogen receptor
- cell therapy
- cell adhesion
- photodynamic therapy
- smooth muscle
- endoplasmic reticulum
- pi k akt
- gene expression
- transcription factor
- deep learning
- bone marrow
- immune response
- artificial intelligence
- human health
- pregnancy outcomes
- type iii